14:24 | 08/01/2025 Print
Chinese health officials are reportedly monitoring an increase in cases of human metapneumovirus (HMPV).
![]() |
There is currently no evidence that the outbreak is out of the ordinary or that a new respiratory virus or illness has emerged in China.
A spokesperson for the World Health Organization (WHO) said data from China indicates "there has been a recent rise in acute respiratory infections" but that "the overall scale and intensity of respiratory infectious diseases in China this year are lower than last year."
Cases of HMPV have been steadily increasing in the U.S. since November 2024 with 1.94% of weekly tests positive for HMPV as of Dec. 28, 2024
Human Metapneumovirus (HMPV) is a respiratory virus that belongs to the Paramyxoviridae family, which also includes viruses like RSV (Respiratory Syncytial Virus) and the measles virus. It was first identified in 2001 and is a leading cause of respiratory infections, especially in young children, older adults, and people with weakened immune systems.
HMPV spreads through:
It is most common in the late winter and early spring, similar to other respiratory viruses.
![]() |
HMPV infections can range from mild to severe. Common symptoms include:
Severe cases can lead to complications like bronchiolitis, pneumonia, or even hospitalization.
While anyone can contract HMPV, certain groups are more vulnerable:
HMPV symptoms often resemble those of the flu, RSV, or COVID-19, making diagnosis challenging without lab tests. Common methods include:
There is no specific antiviral treatment for HMPV. Care is typically supportive and focuses on relieving symptoms:
Antibiotics are not effective, as HMPV is a viral infection.
There is currently no vaccine for HMPV, but you can reduce your risk by:
HMPV symptoms overlap with other viruses like RSV, influenza, and COVID-19. Testing is often needed to distinguish among them. HMPV tends to affect a similar demographic as RSV and often co-circulates with it during flu season.
HMPV is one of the most common causes of respiratory infections worldwide, yet it is less well-known compared to RSV or influenza. Studies estimate that HMPV causes up to 10% of hospitalizations and 6% of outpatient visits for respiratory illnesses in children. Awareness of HMPV is critical for timely diagnosis and care, especially for vulnerable populations.
Q: Is HMPV life-threatening?
A: While most cases are mild, HMPV can lead to severe complications like pneumonia or respiratory failure in high-risk groups.
Q: How long does an HMPV infection last?
A: Symptoms typically last 7–10 days, though severe cases may take longer to resolve.
Q: Is HMPV contagious before symptoms appear?
A: Yes, HMPV can be contagious for several days before symptoms begin and up to a week after they subside.
Q: Can you get HMPV more than once?
A: Yes, reinfections can occur, but subsequent infections are usually less severe due to partial immunity.
Q: Are there clinical trials for an HMPV vaccine?
A: Yes, researchers are working on developing vaccines and antivirals for HMPV, though none are currently available.
Jack 100
Article URL: https://knowinsiders.com/what-is-hmpv-could-be-the-next-big-global-health-emergency-like-covid-19-42563.html
All rights reserved by KnowInsider